𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-γ and Granulocyte-Macrophage Colony Stimulating Factor Therapy in Three Patients with Pulmonary Aspergillosis

✍ Scribed by A. Bandera; D. Trabattoni; G. Ferrario; M. Cesari; F. Franzetti; M. Clerici; A. Gori

Book ID
107705702
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
368 KB
Volume
36
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in cytokine production during th
Changes in cytokine production during therapy with Granulocyte-macrophage colony-stimulating factor in patients with chronic hepatitis B
✍ Julio Martín; Juan A. Quiroga; Orencio Bosch; Dr. Vicente Carreño 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Recombinant human granulocyte-macrophage colony-stimulating factor therapy significantly reduces serum hepatitis B virus DNA levels, associated with increased 2',5'-oligoadenylate synthetase activity in cultured mononuclear cells of patients with chronic hepatitis B. To assess changes in immune func

Combination chemotherapy with granulocyt
Combination chemotherapy with granulocyte-macrophage–colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma
✍ Susan Partyka; Pamela Dumas; Jaffer Ajani 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

## BACKGROUND. A combination of etoposide, 5-fluorouracil, and folinic acid (ELF) remains popular for the treatment of patients with gastric carcinoma and has been reported to result in a response rate of up to 40% with good patient tolerance. The authors elected to add granulocyte-macrophage-colo